Azucena Rodriguez-Guardado
Overview
Explore the profile of Azucena Rodriguez-Guardado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alkaissy Y, Serre-Delcor N, Vicente M, Molina I, Norman F, Goikoetxea A, et al.
J Travel Med
. 2024 May;
31(6).
PMID: 38691427
Background: High-speed global travel, increased trade, world population growth, migration, urbanization and climate change have favoured the emergence and spread of pathogens. We aimed to analyse the evolution of imported...
2.
Rodriguez-Guardado A, Alvarez-Martinez M, Flores M, Sulleiro E, Torrus-Tendero D, Velasco M, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2022 Aug;
41(6):329-334.
PMID: 35970704
Introduction: The generalization of treatment with dexamethasone or other immunosuppressants in patients with SARS-CoV-2 infection may increase the risk of occurrence of severe forms of strongyloidiasis. A nationwide survey was...
3.
Norman F, Trevino-Maruri B, Ruiz Giardin J, Gullon-Pena B, Salvador F, Serre N, et al.
J Travel Med
. 2022 Jul;
29(6).
PMID: 35876259
Introduction: The COVID-19 pandemic has caused disruptions in prevention and management strategies for malaria globally. Currently, data analysing trends in travel-related infections during the pandemic years are scarce. The objective...
4.
Palacios-Gutierrez J, Rodriguez-Guardado A, Arias-Guillen M, Alonso-Arias R, Palacios-Penedo S, Garcia-Garcia J, et al.
Arch Bronconeumol
. 2022 Feb;
58(9):649-659.
PMID: 35185258
Background: The clinical and epidemiological implications of abnormal immune responses in COVID-19 for latent tuberculosis infection (LTBI) screening are unclear. Methods: We reviewed QuantiFERON TB Gold Plus (QFT-Plus) results (36,709...
5.
Norman F, Salvador F, Gullon B, Diaz-Menendez M, Perez-Ayala A, Rodriguez-Guardado A, et al.
J Travel Med
. 2022 Feb;
29(7).
PMID: 35166822
Introduction: The objective of this study was to describe the main characteristics of migrants diagnosed with human T-lymphotropic virus (HTLV) infection within the +Redivi Spanish network. Methods: Patients with a...
6.
Rodriguez-Guardado A, Alvarez-Martinez M, Flores M, Sulleiro E, Torrus-Tendero D, Velasco M, et al.
Enferm Infecc Microbiol Clin
. 2021 Dec;
41(6):329-334.
PMID: 34931102
Introduction: The generalization of treatment with dexamethasone or other immunosuppressants in patients with SARS-CoV-2 infection may increase the risk of occurrence of severe forms of strongyloidiasis. A nationwide survey was...
7.
Fernandez-Martinez J, Boga J, de Andres-Galiana E, Casado L, Fernandez J, Menendez C, et al.
Am J Trop Med Hyg
. 2021 Sep;
105(5):1413-1419.
PMID: 34544039
Given the high prevalence of imported diseases in immigrant populations, it has postulated the need to establish screening programs that allow their early diagnosis and treatment. We present a mathematical...
8.
Salmanton-Garcia J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, et al.
Emerg Infect Dis
. 2021 Feb;
27(4):1077-1086.
PMID: 33539721
Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion caused by this virus and...
9.
Salvador F, Trevino B, Chamorro-Tojeiro S, Pou D, Herrero-Martinez J, Rodriguez-Guardado A, et al.
Pathog Glob Health
. 2020 Dec;
115(2):121-124.
PMID: 33380280
The aim of this study was to describe the clinical and epidemiological profile of immunosuppressed patients with imported strongyloidiasis in a non-endemic setting, and to compare these results with non-immunosuppressed...
10.
Pintado V, Pazos R, Jimenez-Mejias M, Rodriguez-Guardado A, Diaz-Pollan B, Cabellos C, et al.
Infect Dis (Lond)
. 2020 Jul;
52(11):808-815.
PMID: 32648796
Background: Linezolid has good penetration to the meninges and could be an alternative for treatment of meningitis. We assessed the efficacy and safety of linezolid therapy for this infection. Methods:...